Single booster dose with updated bivalent COVID-19 vaccine provides broad protection against COVID-19 including Omicron variant
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 6, 2023, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
On Dec. 21, 2022, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic…
On Dec. 21, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Actemraï¾® (tocilizumab)…
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
On Dec. 15, 2022, the University of Oxford Oxfordï¾’s Ebola vaccine candidate has been shipped to Uganda, just…
On Dec. 14, 2022, the National Institutes of Health announced that two randomized, placebo-controlled trials evaluating three Ebola…
On Dec. 9, 2022, Washington University in St. Louis announced that it’s nasal COVID-19 vaccine technology had been…
On Dec. 8, 2022, the Department of Veterans Affairs embarked on a study to determine the most effective…
On Dec. 7, 2022, Pfizer announced that the U.S. Food and Drug Administration (FDA) had accepted for priority…
On Dec. 7, 2022, scientists reported an ancient environmental DNA6 (eDNA) record describing the rich plant and animal…
On Dec. 5, 2022, a study at the University of Missouri found that nearly 10,000 years ago, humans…
On Dec. 5, 2022, Pfizer and BioNTech announced that the companies had submitted an application to the U.S….
On Nov. 28, 2022, the U.S. Department of Agricultureï¾’s Research Service, Auburn University’s College of Agriculture, and the…
On Nov. 28, 2022, the WHO announced that following a series of consultations with global experts, it had…
On Nov. 27, 2022, it was reported a parasite that infects up to one-third of people around the…
On Nov. 24, 2022, researchers Kanta Horie and Chihiro Sato at the Tracy Family SILQ Center at Washington…
On Nov. 22, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorization for the Lucira…
On Nov. 21, 2022, the National Institutes of Health awarded more than $12 million to three institutions for…
On Nov. 21, 2022, the WHO is launching a global scientific process to update the list of priority…